NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
10 2020
Historique:
received: 30 03 2020
accepted: 17 07 2020
pubmed: 2 9 2020
medline: 7 1 2021
entrez: 2 9 2020
Statut: ppublish

Résumé

Antigen stimulation (signal 1) triggers B cell proliferation and primes B cells to recruit, engage and respond to T cell help (signal 2). Failure to receive signal 2 within a defined time window results in B cell apoptosis, yet the mechanisms that enforce dependence on co-stimulation are incompletely understood. Nr4a1-3 encode a small family of orphan nuclear receptors that are rapidly induced by B cell antigen receptor stimulation. Here, we show that Nr4a1 and Nr4a3 play partially redundant roles to restrain B cell responses to antigen in the absence of co-stimulation and do so, in part, by repressing the expression of BATF and, consequently, MYC. The NR4A family also restrains B cell access to T cell help by repressing expression of the T cell chemokines CCL3 and CCL4, as well as CD86 and ICAM1. Such NR4A-mediated regulation plays a role specifically under conditions of competition for limiting T cell help.

Identifiants

pubmed: 32868928
doi: 10.1038/s41590-020-0765-7
pii: 10.1038/s41590-020-0765-7
pmc: PMC8081071
mid: NIHMS1613365
doi:

Substances chimiques

DNA-Binding Proteins 0
NR4A3 protein, human 0
Nr4a1 protein, mouse 0
Nuclear Receptor Subfamily 4, Group A, Member 1 0
Receptors, Antigen, B-Cell 0
Receptors, Steroid 0
Receptors, Thyroid Hormone 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1267-1279

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI148487
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR069520
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007334
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Bretscher, P. & Cohn, M. A theory of self–nonself discrimination. Science 169, 1042–1049 (1970).
pubmed: 4194660 doi: 10.1126/science.169.3950.1042 pmcid: 4194660
Cyster, J. G. & Allen, C. D. C. B cell responses: cell interaction dynamics and decisions. Cell 177, 524–540 (2019).
pubmed: 31002794 pmcid: 6538279 doi: 10.1016/j.cell.2019.03.016
Damdinsuren, B. et al. Single round of antigen receptor signaling programs naive B cells to receive T cell help. Immunity 32, 355–366 (2010).
pubmed: 20226693 pmcid: 3607434 doi: 10.1016/j.immuni.2010.02.013
Turner, J. S., Marthi, M., Benet, Z. L. & Grigorova, I. Transiently antigen-primed B cells return to naive-like state in absence of T-cell help. Nat. Commun. 8, 15072 (2017).
pubmed: 28429719 pmcid: 5413946 doi: 10.1038/ncomms15072
Akkaya, M. et al. Second signals rescue B cells from activation-induced mitochondrial dysfunction and death. Nat. Immunol. 19, 871–884 (2018).
pubmed: 29988090 pmcid: 6202187 doi: 10.1038/s41590-018-0156-5
Winoto, A. & Littman, D. R. Nuclear hormone receptors in T lymphocytes. Cell 109, S57–S66 (2002).
pubmed: 11983153 doi: 10.1016/S0092-8674(02)00710-9 pmcid: 11983153
Lin, B. et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116, 527–540 (2004).
pubmed: 14980220 doi: 10.1016/S0092-8674(04)00162-X pmcid: 14980220
Thompson, J. & Winoto, A. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J. Exp. Med. 205, 1029–1036 (2008).
pubmed: 18443228 pmcid: 2373836 doi: 10.1084/jem.20080101
Calnan, B. J., Szychowski, S., Chan, F. K., Cado, D. & Winoto, A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 3, 273–282 (1995).
pubmed: 7552993 doi: 10.1016/1074-7613(95)90113-2 pmcid: 7552993
Sekiya, T. et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat. Immunol. 14, 230–237 (2013).
pubmed: 23334790 doi: 10.1038/ni.2520
Chen, J. et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567, 530–534 (2019).
pubmed: 30814732 pmcid: 6546093 doi: 10.1038/s41586-019-0985-x
Liu, X. et al. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature 567, 525–529 (2019).
pubmed: 30814730 pmcid: 6507425 doi: 10.1038/s41586-019-0979-8
Cheng, L. E. C., Chan, F. K., Cado, D. & Winoto, A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J. 16, 1865–1875 (1997).
pubmed: 9155013 pmcid: 1169790 doi: 10.1093/emboj/16.8.1865
Moran, A. E. et al. T cell receptor signal strength in T
pubmed: 21606508 pmcid: 3173240 doi: 10.1084/jem.20110308
Mullican, S. E. et al. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat. Med. 13, 730–735 (2007).
pubmed: 17515897 doi: 10.1038/nm1579
Mueller, J., Matloubian, M. & Zikherman, J. Cutting edge: an in vivo reporter reveals active B cell receptor signaling in the germinal center. J. Immunol. 194, 2993–2997 (2015).
pubmed: 25725108 pmcid: 4369439 doi: 10.4049/jimmunol.1403086
Zikherman, J., Parameswaran, R. & Weiss, A. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 489, 160–164 (2012).
pubmed: 22902503 pmcid: 3438375 doi: 10.1038/nature11311
Noviski, M. et al. Optimal development of mature B cells requires recognition of endogenous antigens. J. Immunol. 203, 418–428 (2019).
pubmed: 31167773 pmcid: 6668988 doi: 10.4049/jimmunol.1900175
Tan, C. et al. Nur77 links chronic antigen stimulation to B cell tolerance by restricting the survival of self-reactive B cells in the periphery. J. Immunol. 202, 2907–2923 (2019).
pubmed: 30962292 pmcid: 6504591 doi: 10.4049/jimmunol.1801565
Huang, B., Pei, H. Z., Chang, H. W. & Baek, S. H. The E3 ubiquitin ligase Trim13 regulates Nur77 stability via casein kinase 2α. Sci. Rep. 8, 13895 (2018).
pubmed: 30224829 pmcid: 6141542 doi: 10.1038/s41598-018-32391-5
Paus, D. et al. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203, 1081–1091 (2006).
pubmed: 16606676 pmcid: 2118299 doi: 10.1084/jem.20060087
Sonoda, E. et al. B cell development under the condition of allelic inclusion. Immunity 6, 225–233 (1997).
pubmed: 9075923 doi: 10.1016/S1074-7613(00)80325-8
Lee, S. L. et al. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 269, 532–535 (1995).
pubmed: 7624775 doi: 10.1126/science.7624775
Hobeika, E. et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl Acad. Sci. USA 103, 13789–13794 (2006).
pubmed: 16940357 doi: 10.1073/pnas.0605944103
Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117, 787–800 (2004).
pubmed: 15186779 doi: 10.1016/j.cell.2004.05.014
Huizar, J., Tan, C., Noviski, M., Mueller, J. L. & Zikherman, J. Nur77 is upregulated in B-1a cells by chronic self-antigen stimulation and limits generation of natural IgM plasma cells. Immunohorizons 1, 188–197 (2017).
pubmed: 29152611 pmcid: 5687085 doi: 10.4049/immunohorizons.1700048
Fowler, T. et al. Divergence of transcriptional landscape occurs early in B cell activation. Epigenet. Chromatin 8, 20 (2015).
doi: 10.1186/s13072-015-0012-x
Zaretsky, I. et al. ICAMs support B cell interactions with T follicular helper cells and promote clonal selection. J. Exp. Med. 214, 3435–3448 (2017).
pubmed: 28939548 pmcid: 5679169 doi: 10.1084/jem.20171129
Shiow, L. R. et al. CD69 acts downstream of interferon-α/β to inhibit S1P
pubmed: 16525420 doi: 10.1038/nature04606
Li, S. et al. The transcription factors Egr2 and Egr3 are essential for the control of inflammation and antigen-induced proliferation of B and T cells. Immunity 37, 685–696 (2012).
pubmed: 23021953 pmcid: 3477314 doi: 10.1016/j.immuni.2012.08.001
Betz, B. C. et al. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 207, 933–942 (2010).
pubmed: 2867277 pmcid: 2867277 doi: 10.1084/jem.20091548
Taub, D. D., Conlon, K., Lloyd, A. R., Oppenheim, J. J. & Kelvin, D. J. Preferential migration of activated CD4
pubmed: 7682337 doi: 10.1126/science.7682337 pmcid: 7682337
Shrestha, B. et al. B cell-derived vascular endothelial growth factor A promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. J. Immunol. 184, 4819–4826 (2010).
pubmed: 20308631 doi: 10.4049/jimmunol.0903063 pmcid: 20308631
Krzysiek, R. et al. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 α (MIP-1α) and MIP-1β chemokine production in human B cells. J. Immunol. 162, 4455–4463 (1999).
pubmed: 10201982 pmcid: 10201982
Nowyhed, H. N., Huynh, T. R., Thomas, G. D., Blatchley, A. & Hedrick, C. C. Cutting edge: the orphan nuclear receptor Nr4a1 regulates CD8
pubmed: 26363057 pmcid: 4592102 doi: 10.4049/jimmunol.1403027
Finkin, S., Hartweger, H., Oliveira, T. Y., Kara, E. E. & Nussenzweig, M. C. Protein amounts of the MYC transcription factor determine germinal center B cell division capacity. Immunity 51, 324–336.e5 (2019).
pubmed: 31350178 pmcid: 6703930 doi: 10.1016/j.immuni.2019.06.013
Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626–3636 (2014).
pubmed: 24616478 pmcid: 3984038 doi: 10.4049/jimmunol.1302062
Heinzel, S. et al. A Myc-dependent division timer complements a cell-death timer to regulate T cell and B cell responses. Nat. Immunol. 18, 96–103 (2017).
pubmed: 27820810 doi: 10.1038/ni.3598 pmcid: 27820810
Ma, Y. et al. CRISPR/Cas9 screens reveal Epstein–Barr virus-transformed B cell host dependency factors. Cell Host Microbe 21, 580–591.e7 (2017).
pubmed: 28494239 doi: 10.1016/j.chom.2017.04.005 pmcid: 28494239
Inoue, T. et al. The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J. Exp. Med. 214, 1181–1198 (2017).
pubmed: 28351982 pmcid: 5379976 doi: 10.1084/jem.20161263
Wingate, A. D. & Arthur, J. S. Post-translational control of Nur77. Biochem. Soc. Trans. 34, 1107–1109 (2006).
pubmed: 17073761 doi: 10.1042/BST0341107
Masuyama, N. et al. Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J. Biol. Chem. 276, 32799–32805 (2001).
pubmed: 11438550 doi: 10.1074/jbc.M105431200
Pekarsky, Y. et al. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl Acad. Sci. USA 98, 3690–3694 (2001).
pubmed: 11274386 doi: 10.1073/pnas.051003198
Glasmacher, E. et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1–IRF complexes. Science 338, 975–980 (2012).
pubmed: 22983707 pmcid: 5789805 doi: 10.1126/science.1228309
Li, P. et al. BATF–JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543–546 (2012).
pubmed: 22992523 pmcid: 22992523 doi: 10.1038/nature11530
Schraml, B. U. et al. The AP-1 transcription factor Batf controls T
pubmed: 2716014 pmcid: 2716014 doi: 10.1038/nature08114
Thomas, M. D., Kremer, C. S., Ravichandran, K. S., Rajewsky, K. & Bender, T. P. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23, 275–286 (2005).
pubmed: 16169500 doi: 10.1016/j.immuni.2005.08.005
Schwickert, T. A. et al. A dynamic T cell–limited checkpoint regulates affinity-dependent B cell entry into the germinal center. J. Exp. Med. 208, 1243–1252 (2011).
pubmed: 21576382 pmcid: 3173244 doi: 10.1084/jem.20102477
Kuraoka, M. et al. Complex antigens drive permissive clonal selection in germinal centers. Immunity 44, 542–552 (2016).
pubmed: 26948373 pmcid: 4794380 doi: 10.1016/j.immuni.2016.02.010
Zhan, Y. et al. Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat. Chem. Biol. 4, 548–556 (2008).
pubmed: 18690216 doi: 10.1038/nchembio.106
Zhan, Y. et al. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nat. Chem. Biol. 8, 897–904 (2012).
pubmed: 22983157 doi: 10.1038/nchembio.1069
Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676–682 (1988).
pubmed: 3261841 doi: 10.1038/334676a0
Barnden, M. J., Allison, J., Heath, W. R. & Carbone, F. R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34–40 (1998).
pubmed: 9553774 doi: 10.1046/j.1440-1711.1998.00709.x
Renshaw, B. R. et al. Humoral immune responses in CD40 ligand–deficient mice. J. Exp. Med. 180, 1889–1900 (1994).
pubmed: 7964465 doi: 10.1084/jem.180.5.1889
Mombaerts, P. et al. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360, 225–231 (1992).
pubmed: 1359428 doi: 10.1038/360225a0
Wholey, W. Y. et al. Synthetic liposomal mimics of biological viruses for the study of immune responses to infection and vaccination. Bioconjug. Chem. 31, 685–697 (2020).
pubmed: 31940172 doi: 10.1021/acs.bioconjchem.9b00825

Auteurs

Corey Tan (C)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.
Biomedical Sciences (BMS) Graduate Program, University of California, San Francisco, CA, USA.

Ryosuke Hiwa (R)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.

James L Mueller (JL)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.

Vivasvan Vykunta (V)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.

Kenta Hibiya (K)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.

Mark Noviski (M)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.
Biomedical Sciences (BMS) Graduate Program, University of California, San Francisco, CA, USA.

John Huizar (J)

HHMI Medical Fellows Program, School of Medicine, University of California, San Francisco, CA, USA.

Jeremy F Brooks (JF)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.

Jose Garcia (J)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.

Cheryl Heyn (C)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA.

Zhongmei Li (Z)

J. David Gladstone Institutes, San Francisco, CA, USA.
Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA.
Department of Microbiology and Immunology, University of California, San Francisco, CA, USA.
Innovative Genomics Institute, University of California, Berkeley, CA, USA.
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
Chan Zuckerberg Biohub, San Francisco, CA, USA.

Alexander Marson (A)

J. David Gladstone Institutes, San Francisco, CA, USA.
Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA, USA.
Department of Microbiology and Immunology, University of California, San Francisco, CA, USA.
Innovative Genomics Institute, University of California, Berkeley, CA, USA.
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
Chan Zuckerberg Biohub, San Francisco, CA, USA.

Julie Zikherman (J)

Division of Rheumatology, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, Department of Medicine, University of California, San Francisco, CA, USA. julie.zikherman@ucsf.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH